Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Julie A Barta"'
Publikováno v:
Preventive Medicine Reports, Vol 44, Iss , Pp 102820- (2024)
Background: Although lung cancer screening (LCS) reduces lung cancer mortality among high-risk individuals, uptake overall remains low. With all cancer screening modalities, a period of diffusion among medical providers and the public is expected, wi
Externí odkaz:
https://doaj.org/article/1446d8a8ad764fd992c4cfa9a9e05f94
Autor:
Christine S. Shusted, Hee-Soon Juon, Brooke Ruane, Brian Till, Charnita Zeigler-Johnson, Russell K. McIntire, Tyler Grenda, Olugbenga Okusanya, Nathaniel R. Evans, Gregory C. Kane, Julie A. Barta
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Although lung cancer screening (LCS) for high-risk individuals reduces lung cancer mortality in clinical trial settings, many questions remain about how to implement high-quality LCS in real-world programs. With the increasing use
Externí odkaz:
https://doaj.org/article/db2afe6dff1548139fd42785e305f5f9
Autor:
Joy Zhao, Julie A. Barta, Russell McIntire, Christine Shusted, Charnita Zeigler-Johnson, Hee-Soon Juon
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background The inverse relationship between BMI and lung cancer diagnosis is well defined. However, few studies have examined the racial differences in these relationships. The purpose of this paper is to explore the relationships amongst ra
Externí odkaz:
https://doaj.org/article/3b0fecdf0500421f81de8c290c0672cd
Autor:
Michael Lake, Christine S. Shusted, Hee-Soon Juon, Russell K. McIntire, Charnita Zeigler-Johnson, Nathaniel R. Evans, Gregory C. Kane, Julie A. Barta
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Racial disparities are well-documented in preventive cancer care, but they have not been fully explored in the context of lung cancer screening. We sought to explore racial differences in lung cancer screening outcomes within a lu
Externí odkaz:
https://doaj.org/article/1b93767f7e544d68991bfa6a2b5ffd69
Autor:
Constantine Daskalakis, Ayako Shimada, Ronald E. Myers, Kathleen Eastburn, Melissa A. DiCarlo, Christine S. Shusted, Julie A. Barta
Publikováno v:
Annals of the American Thoracic Society. 20:756-758
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f72c3a4b4d2bb01c316b524c9825bfb
https://doi.org/10.1513/annalsats.202211-937rl
https://doi.org/10.1513/annalsats.202211-937rl
Publikováno v:
Clinical Lung Cancer. 23:e453-e459
Pulmonary carcinoid tumor (PCT) is a rare neuroendocrine lung neoplasm comprising approximately 2% of lung cancer diagnoses. It is classified as either localized low-grade (typical) or intermediate-grade (atypical) subtypes. PCT is known clinically t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce8d42717539e10f3d27db2b8678607
https://doi.org/10.1016/j.cllc.2022.06.006
https://doi.org/10.1016/j.cllc.2022.06.006
Publikováno v:
The American Journal of the Medical Sciences. 364:371-378
Lung cancer remains the leading cause of cancer death in the United States and is unfortunately still frequently diagnosed in the metastatic setting, where the disease is considered incurable. Nearly 30% of these cancers may be driven by specific mut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5478697117e008ba5dfc4a5c47837d
https://doi.org/10.1016/j.amjms.2022.04.019
https://doi.org/10.1016/j.amjms.2022.04.019
Facility-level national trends in racial disparities of surgical therapy for early-stage lung cancer
Autor:
Samantha L. Savitch, Tyler R. Grenda, Misung Yi, Brian Till, Shale Mack, Charles Huang, Julie A. Barta, Nathaniel R. Evans, Olugbenga T. Okusanya
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 164:650-657
The racial gap in surgical treatment for early-stage non-small cell lung cancer (NSCLC) has been narrowing at the population level, but it is unknown if this trend persists at the facility level.We queried the National Cancer Database Participant Use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ffd7af99a51d1c58aafdf0bd9bf9453
https://doi.org/10.1016/j.jtcvs.2021.11.081
https://doi.org/10.1016/j.jtcvs.2021.11.081
Publikováno v:
Annals of Global Health, Vol 85, Iss 1 (2019)
While lung cancer has been the leading cause of cancer-related deaths for many years in the United States, incidence and mortality statistics – among other measures – vary widely worldwide. The aim of this study was to review the evidence on lung
Externí odkaz:
https://doaj.org/article/4ae20ff1433848d5b7c6418b963f54bc
Autor:
Christine Shusted, Hee-Soon Juon, Brooke Ruane, Brian Till, Charnita Zeigler-Johnson, Russell K. McIntire, Tyler Grenda, Olugbenga Okusanya, Nathaniel R. Evans, Gregory C. Kane, Julie A. Barta
Background: Although lung cancer screening (LCS) for high-risk individuals reduces lung cancer mortality in clinical trial settings, many questions remain about how to implement high-quality LCS in real-world programs. With the increasing use of tele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64b606904401a5b2dc3c3d5d16627e33
https://doi.org/10.21203/rs.3.rs-2257444/v1
https://doi.org/10.21203/rs.3.rs-2257444/v1
